3D volume and SUV analysis of oncological PET studies: A voxel-based image processing tool with NSCLC as example;Dreidimensionale uptake-und volumenanalyse von onkologischen PET-studien: Voxel-basiertes bildverarbeitungstool am beispiel von NSCLC

NuklearMedizin

Volumn 46, Issue 4, 2007, Pages 141-148

  Krohn, Thomas ^a   Kaiser, H J ^a   Gagel, B ^a   Boy, C ^a   Schaefer, W M ^a   Buell, U ^a   Zimny, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

3D; FDG; PET; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALGORITHM; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HUMAN; IMAGE QUALITY; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VOLUMETRY;

ALGORITHMS; COMPUTER SIMULATION; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; NEOPLASMS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 34548383101     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1160/nukmed-0052     Document Type: Article

References (22)

1. Adams R, Bischof L. Seeded Region Growing. IEEE Trans Pattern Anal Machine Intell 1994; 16: 641-647.
2. 18F-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol 2006; 23: 7445-7453.
3. Avril N, Schelling M, Dose J et al. Utility of PET in Breast Cancer. Clin Positron Imaging 1999; 2: 261-271.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
5. Borst GR, Belderbos JS, Boellaard R et al. Standardised FDG uptake: a prognostic factor for inoperale non-small cell lung cancer. Eur J Cancer 2005; 41: 1533-1541.
6. 18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluation: analysis of 921 lesions. Nuklearmedizin 2004; 43: 210-216.
7. 18F-FDG PET is an early predictor of pathologic tumor response to preoperativeradiochemotherapy in locally advanced rectal cancer. J Nucl Med 2006; 47: 1241-1248.
8. Cremerius U, Fabry U, Neuerburg J et al. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma. Nuklearmedizin 2001; 40: 23-30.
9. Erdi YE, Mawlawi O, Larson SM et al. Segmentation of Lung Lesion Volume by Adaptive Positron Emission Tomography Image Thresholding. Cancer Suppl 1997; 80: 2505-2509.
10. Erdi YE, Wessels BW, Loew MH et al. Threshold estimation in single photon emission computed tomography and planar imaging for clinical radioimmunotherapy. Cancer Res 1995; 55: 5823s-5826s.
11. 18F-fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 2006; 6: 51.
12. Gonzales RC, Wintz P. Digital Image Processing. Addison Wesley 1987; 368-375.
13. Kessler RM, Ellis JR jr, Eden M. Analysis of emission tomographic data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984; 8: 514-522.
14. Hellwig D, Groschel A, Graeter TP et al. Diagnostic performance and prognostic impact of FDG-PET in suspected recurence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2006; 33: 13-21.
15. 18F-FDG PET compared to CT/MRI. Nuklearmedizin 1999; 38: 312-318.
16. Poetzsch C, Hofheinz F, van den Hoff J. Vergleich der Inter-Observer-Variabilität bei manueller und automatischer Volumenbestimmung in der PET. Nuklearmedizin 2006; 45: A42.
17. Reinartz P, Wieres FJ, Schneider W et al. Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 2004; 31: 1456-1461.
18. Sachs S, Bilfinger TV, Komaroff E et al. Increased standardized uptake vlue in the primary lesion predicts nodal or distand metastases at presentation in lung cancer. Clin Lung Cancer 2005; 6: 310-313.
19. 18F-FDG PET for detecting recurrent head and neck cancer, local lymph node involvement and distant metastases. Comparison of qualitative visual and semiquantitative analysis. Nuklearmedizin 2004; 43: 91-101.
20. Weber WA, Petersen V, Schmidt B et al. Positron emission tomography in non-small cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 2003; 21: 2651-2657.
21. Weber WA, Ziegler SI, Thodtmann R et al. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999; 40: 1771-1777.
22. Zimny M, Fass J, Bares R et al. Fluorodeoxyglucose positron emission tomography and the prognosis of pancreatic carcinoma. Scand J Gastroenterol 2000; 35: 883-888.